Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a tiny dose of naltrexone relieve HIV nerve pain without opioids?

NCT ID NCT05537935

First seen Apr 17, 2026 · Last updated May 22, 2026 · Updated 7 times

Summary

This study tests whether a very low dose of naltrexone, a drug usually used for addiction, can reduce chronic nerve pain in people with HIV. Researchers will enroll 60 adults with HIV and neuropathic pain to take the drug for 12 weeks and report their pain levels. The goal is to find a safer, non-opioid option for pain relief that might also improve immune function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory Midtown Hospital

    RECRUITING

    Atlanta, Georgia, 30308, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Emory University Hospital

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Grady Memorial Hospital

    RECRUITING

    Atlanta, Georgia, 30303, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.